FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Check out our top picks below. If you are looking for a powerful allergy nasal spray that provides 24-hour all-in-one relief for even your worst seasonal, year-round, indoor, and outdoor allergy ...

Forty-eight subjects each received one oral and one intranasal dose of 2.5 or 5mg zolmitriptan, with a 72-hour washout ... of zolmitriptan nasal spray may explain the faster relief from migraine ...

Nasal sprays can be an effective medication option to manage migraine symptoms. Often, nasal sprays can provide faster relief than oral ... available as a nasal spray, to help manage migraine ...

However, the researchers did not think there was enough evidence to support nasal sprays as a treatment for COVID or as a way to prevent COVID. If you have COVID and are looking for relief from nasal ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for ... that in as little as 24 hours, patients will start getting relief from the esketamine treatment, and ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first ... symptoms as early as 24 hours and at 28 days ...

This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato ... symptoms in as little as 24 hours. Johnson & Johnson said that ...